Why the study?
Does hypertonic sodium and/or dantrolene reverse propranolol cardiotoxicity in isolated rat hearts?
Does hypertonic sodium and/or dantrolene reverse propranolol cardiotoxicity in isolated rat hearts?
Combined hypertonic sodium and dantrolene can reverse propranolol-induced bradycardia and pacing refractoriness in an isolated rat heart model, suggesting altered calcium homeostasis mediates beta-blocker cardiotoxicity.
Answers are grounded in this paper and cite their sources.
May support combined therapy for propranolol toxicity; hypothesis-generating in this animal model and should not change practice.
OBJECTIVE: To evaluate whether measures that lower cytosolic calcium (Ca) can reverse propranolol (PROP) toxicity in the isolated, perfused rat heart. METHODS: Isolated rat hearts were perfused on a Langendorff apparatus with Krebs-Henseleit-bicarbonate (KHB) buffer solution. Toxicity was produced by perfusing the hearts with PROP (5 micrograms/mL) for 30 minutes. Subsequently, the hearts were treated for 30 minutes with buffer containing PROP plus experimental treatment. Three treatments were chosen: hypertonic sodium (Na) (160 mmol), to stimulate Na-Ca exchange, dantrolene (DAN) (10 mumol), to inhibit Ca release from sarcoplasmic reticulum, and combined hypertonic Na and DAN. The hearts were paced after 20 minutes of treatment. Heart rate (HR), left ventricular peak systolic pressure (LVP), the first derivative of LVP (dP/dt), and coronary flow were measured. RESULTS: PROP decreased HR and rendered the hearts refractory to pacing. PROP did not alter dP/dt. PROP increased LVP consistent with increased cytosolic Ca. Combined hypertonic Na and DAN treatment restored the ability to pace PROP-toxic hearts to the basal HR. Individually, hypertonic Na or DAN treatment partially restored the ability to pace toxic hearts. As experimental treatments increased HR, dP/dt and LVP decreased, consistent with decreased cytosolic Ca availability. CONCLUSION: These data are consistent with the hypothesis that bradycardia during beta-blocker cardiotoxicity is mediated by altered Ca homeostasis.
No takes yet. Share an insight, caveat, or question.
Kerns et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: